MedTrace Logo

A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease

NCT04487301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2021-10-14

No results posted yet for this study

Summary

A cross-sectional, non-interventional study to assess walking performance, vascular function, and lower limb calcification in subjects with peripheral artery disease and end-stage kidney disease (PAD-ESKD) receiving hemodialysis.

Conditions

Sponsors & Collaborators

  • Sanifit Therapeutics S. A.

    lead OTHER

Principal Investigators

  • Alex Gold, MD · Sanifit Therapeutics

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-16
Primary Completion
2021-06-12
Completion
2021-06-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04487301 on ClinicalTrials.gov